Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Murat

Showing results (261-270 of 263) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 263 results.
Future Oncology (London, England)|October 17, 2025
Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access programDeniz Tural, Oğuzcan Özkan, Eda Eylemer Mocan, et al.
The Oncologist|September 7, 2023
Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology GroupÇağlar Ünal, Abdulmunir Azizy, Senem Karabulut, et al.
Cancers|June 26, 2026
Real-World Outcomes and Progression Patterns with First-Line Osimertinib in Patients with Advanced <i>EGFR</i>-Mutant Non-Small Cell Lung Cancer: A Nationwide Turkish Oncology Group StudyBahadır Köylü, Özde Melisa Celayir, Harun Muğlu, et al.
Pageof 27

Showing results (261-270 of 263) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 263 results.
Future Oncology (London, England)|October 17, 2025
Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access programDeniz Tural, Oğuzcan Özkan, Eda Eylemer Mocan, et al.
The Oncologist|September 7, 2023
Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology GroupÇağlar Ünal, Abdulmunir Azizy, Senem Karabulut, et al.
Cancers|June 26, 2026
Real-World Outcomes and Progression Patterns with First-Line Osimertinib in Patients with Advanced <i>EGFR</i>-Mutant Non-Small Cell Lung Cancer: A Nationwide Turkish Oncology Group StudyBahadır Köylü, Özde Melisa Celayir, Harun Muğlu, et al.
Pageof 27